"Ecstasy"-induced toxicity in SH-SY5Y differentiated cells: role of hyperthermia and metabolites

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Archives of Toxicology

• Publication date

  2014-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00204-013-1147-9PMID 24177245
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The mixture of “ecstasy” and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations

  2013cited by this paper
• In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin2A Receptor Binding in 3,4-Methylenedioxymethamphetamine (MDMA or “Ecstasy”) and Hallucinogen Users

  2012cited by this paper
• Pro‐oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes

  2012cited by this paper
• Toxicity of amphetamines: an update

  2012cited by this paper
• MDMA and 5‐HT neurotoxicity: the empirical evidence for its adverse effects in humans – no need for translation

  2012cited by this paper
• Persistent Nigrostriatal Dopaminergic Abnormalities in Ex-Users of MDMA (‘Ecstasy’): An 18F-Dopa PET Study

  2011cited by this paper
• Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.

  2011cited by this paper
• In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.

  2011cited by this paper
• Pro-oxidant effects of “ecstasy” and its metabolites in mouse brain synaptosomes

  2011cited by this paper
• Neurotoxicity of "ecstasy" and its metabolites in human dopaminergic differentiated SH-SY5Y cells.

  2010cited by this paper
• Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study

  2010cited by this paper
• THC Prevents MDMA Neurotoxicity in Mice

  2010cited by this paper
• Chronic Stress Enhances the Corticosterone Response and Neurotoxicity to +3,4-Methylenedioxymethamphetamine (MDMA): The Role of Ambient Temperature

  2010cited by this paper
• Synthesis and in vitro cytotoxicity profile of the R-enantiomer of 3,4-dihydroxymethamphetamine (R-(-)-HHMA): comparison with related catecholamines.

  2010cited by this paper
• The role of monoamines in the changes in body temperature induced by 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives

  2010cited by this paper
• Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.

  2010cited by this paper
• Learning and memory deficits in ecstasy users and their neural correlates during a face-learning task.

  2009cited by this paper
• Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists

  2009influential reference
• Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone‐induced Parkinson's disease models

  2009cited by this paper
• Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology.

  2009influential reference
• Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview

  2009cited by this paper
• Metabolites of MDMA Induce Oxidative Stress and Contractile Dysfunction in Adult Rat Left Ventricular Myocytes

  2009cited by this paper
• Modulation of Human Multidrug Resistance Protein (MRP) 1 (ABCC1) and MRP2 (ABCC2) Transport Activities by Endogenous and Exogenous Glutathione-Conjugated Catechol Metabolites

  2008cited by this paper
• Accumulation of Neurotoxic Thioether Metabolites of 3,4-(±)-Methylenedioxymethamphetamine in Rat Brain

  2008influential reference
• Neurotoxicity mechanisms of thioether ecstasy metabolites.

  2007cited by this paper
• Upregulation of gamma-glutamate-cysteine ligase as part of the long-term adaptation process to iron accumulation in neuronal SH-SY5Y cells.

  2007cited by this paper
• Neuronal differentiation and long-term culture of the human neuroblastoma line SH-SY5Y.

  2007cited by this paper
• Evaluation of GSH adducts of adrenaline in biological samples.

  2007cited by this paper
• Synthesis and cyclic voltammetry studies of 3,4-methylenedioxymethamphetamine (MDMA) human metabolites

  2007cited by this paper
• Upregulation of γ-glutamate-cysteine ligase as part of the long-term adaptation process to iron accumulation in neuronal SH-SY5Y cells

  2007cited by this paper
• Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia.

  2006cited by this paper
• Neurotoxicity of Ecstasy Metabolites in Rat Cortical Neurons, and Influence of Hyperthermia

  2006cited by this paper
• Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: Temporal, spatial, and cellular patterns

  2006cited by this paper
• Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction

  2006cited by this paper
• A comparative study on the acute and long‐term effects of MDMA and 3,4‐dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice

  2005cited by this paper
• Serotonergic Neurotoxic Metabolites of Ecstasy Identified in Rat Brain

  2005influential reference
• The toxicity of N-methyl-α-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine

  2004cited by this paper
• The Role of Metabolism in 3,4-(±)-Methylenedioxyamphetamine and 3,4-(±)-Methylenedioxymethamphetamine (Ecstasy) toxicity

  2004influential reference
• Progressive iron accumulation induces a biphasic change in the glutathione content of neuroblastoma cells.

  2004cited by this paper
• Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans.

  2004cited by this paper
• Metabolism is required for the expression of ecstasy-induced cardiotoxicity in vitro.

  2004cited by this paper
• Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA.

  2003cited by this paper
• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

  2003cited by this paper
• Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells

  2002cited by this paper
• Serotonergic neurotoxicity of 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase.

  2001cited by this paper
• Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes

  2001cited by this paper
• 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

  2001influential reference
• Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity.

  1999influential reference
• Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery

  1999cited by this paper
• 3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: effect on cytosolic calcium signals in isolated hepatocytes.

  1999cited by this paper
• Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat

  1998cited by this paper
• Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion.

  1996influential reference
• Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats.

  1996influential reference
• Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX.

  1995cited by this paper
• Quinone-induced oxidative stress elevates glutathione and induces gamma-glutamylcysteine synthetase activity in rat lung epithelial L2 cells.

  1994cited by this paper
• Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans

  1994cited by this paper
• Brain uptake of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine, the glutathione and cysteine S-conjugates of the neurotoxin dichloroacetylene.

  1993cited by this paper
• Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

  1992cited by this paper
• High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.

  1992cited by this paper
• Ecstasy, 3–4 Methylenedioxymethamphetamine (MDMA), a Fatality Associated with Coagulopathy and Hyperthermia

  1991cited by this paper
• Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct.

  1990cited by this paper
• Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA.

  1989influential reference
• Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration.

  1988cited by this paper
• Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.

  1987cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951influential reference

• Potential Transmembrane Proteins-transporters of Chelidonic Acid for its Intracellular Uptake: In Silico Simulation

  2025cites this paper
• Glycolytic Inhibitors Potentiated the Activity of Paclitaxel and Their Nanoencapsulation Increased Their Delivery in a Lung Cancer Model

  2022cites this paper
• Ecstasy metabolites and monoamine neurotransmitters upshift the Na+/K+ ATPase activity in mouse brain synaptosomes

  2022cites this paper
• Caffeine and MDMA (Ecstasy) Exacerbate ER Stress Triggered by Hyperthermia

  2022cites this paper
• S-(+)-pentedrone and R-(+)-methylone as the most oxidative and cytotoxic enantiomers to dopaminergic SH-SY5Y cells: Role of MRP1 and P-gp in cathinones enantioselectivity.

  2021cites this paper
• Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: toxicological effect of surface charge on human neuronal cells.

  2021cites this paper
• Para-Halogenation of Amphetamine and Methcathinone Increases the Mitochondrial Toxicity in Undifferentiated and Differentiated SH-SY5Y Cells

  2020cites this paper
• MDMA hepatotoxicity under heat stress condition: novel insights from in vitro metabolomic studies.

  2020cites this paper
• Hyperthermia Increases Neurotoxicity Associated with Novel Methcathinones

  2020influential citation
• Model Amphipathic Peptide Coupled with Tacrine to Improve Its Antiproliferative Activity

  2020cites this paper
• Molecular toxicological mechanisms of new psychoactive substances "in vitro"

  2020cites this paper
• Oxygenated xanthones as P-glycoprotein modulators at the intestinal barrier: in vitro and docking studies

  2020cites this paper
• Evaluation of the biocompatibility and skin hydration potential of vitamin E-loaded lipid nanosystems formulations: In vitro and human in vivo studies.

  2019cites this paper
• Power and exponentials laws: Theory and application

  2019cites this paper
• Metabolic profiling analysis of corilagin in vivo and in vitro using high‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry

  2019cites this paper
• Research into the toxicological mechanisms of tramadol and tapentadol: clinical and forensic aspects

  2018cites this paper
• Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski’s Rule of Five

  2018cites this paper
• Neurotoxicity of β-Keto Amphetamines: Deathly Mechanisms Elicited by Methylone and MDPV in Human Dopaminergic SH-SY5Y Cells.

  2017cites this paper
• Amphetamine‐related drugs neurotoxicity in humans and in experimental animals: Main mechanisms

  2017cites this paper
• In vitro cellular models for neurotoxicity studies : neurons derived from P19 cells

  2017cites this paper
• Uncovering the hepatotoxic and neurotoxic potential of ß-keto amphetamine (cathinone) derivates: in vitro mechanistic studies.

  2017cites this paper
• Comparative study of the neurotoxicological effects of tramadol and tapentadol in SH-SY5Y cells.

  2016cites this paper
• 3,4-methylenedioxypyrovalerone (MDPV) Induces Cytotoxic Effects on Human Dopaminergic SH-SY5Y Cells

  2016cites this paper
• Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity.

  2016cites this paper
• In vitro neurotoxicity evaluation of piperazine designer drugs in differentiated human neuroblastoma SH‐SY5Y cells

  2016influential citation
• Mitochondrial Trails in the Neurotoxic Mechanisms of MDMA

  2016cites this paper
• Full Title: COMPARATIVE STUDY OF THE NEUROTOXICOLOGICAL EFFECTS OF TRAMADOL AND TAPENTADOL IN SH-SY5Y CELLS Running Head: Tramadol and tapentadol neuronal toxicity

  2016cites this paper
• In Vitro Toxicity Evaluation Of Piperazine Designer Drugs

  2015cites this paper
• In vitro models for neurotoxicology research

  2015cites this paper
• Mitochondria: key players in the neurotoxic effects of amphetamines

  2015influential citation
• Highlight report: acetaminophen hepatotoxicity

  2015cites this paper
• Piperazine designer drugs induce toxicity in cardiomyoblast h9c2 cells through mitochondrial impairment.

  2014cites this paper
• Modeling chronic brain exposure to amphetamines using primary rat neuronal cortical cultures.

  2014cites this paper
• MDMA impairs mitochondrial neuronal trafficking in a Tau- and Mitofusin2/Drp1-dependent manner

  2014cites this paper
• Neuronal Mitochondrial Trafficking Impairment: The Cause or a Consequence of Neuronal Dysfunction Caused by Amphetamine-Like Drugs

  2014cites this paper
• The mixture of "ecstasy" and its metabolites impairs mitochondrial fusion/fission equilibrium and trafficking in hippocampal neurons, at in vivo relevant concentrations.

  2014cites this paper
• Brain and Peripheral Organ Toxicity of "Ecstasy" in Adolescent Rats in Human Relevant Doses

  2014cites this paper